Inhibition of DNA methyltransferase activates tumor necrosis factor α-induced monocytic differentiation in acute myeloid leukemia cells

Anna Laurenzana, Luca A. Petruccelli, Filippa Pettersson, Maria Figueroa, Ari Melnick, Albert S. Baldwin, Francesco Paoletti, Wilson H. Miller

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Transcriptional silencing via promoter methylation of genes important for cell growth and differentiation plays a key role in myeloid leukemogenesis. We find that clinically achievable levels of 5-aza-2′-deoxycytidine (5-AZA-dC), a potent inhibitor of DNA methylation, can modify chromatin and restore the ability of tumor necrosis factor α (TNFα) to induce monocytic differentiation of the acute myeloid leukemia cells NB4 and U937. Although 5-AZA-dC cannot fully induce differentiation, we show that 5-AZA-dC acts directly on TNFα-responsive promoters to facilitate TNFα-induced transcriptional pathways leading to differentiation. 5-AZA-dC regulates the expression of Dif-2, a TNFα target gene, by deacetylating chromatin domains in a methylation-dependent manner. Chromatin immunoprecipitation analyses of the Dif-2 promoter show histone hyperacetylation and a recruitment of the nuclear factor-κB transcription factor in response to 5-AZA-dC. Furthermore, 5-AZA-dC plus TNFα enhances the level of phosphorylated RNAP ol II at the Dif-2 promoter via synergistic recruitment of TFIIH. We conclude that nonspecific changes in chromatin can allow a specific transcriptional inducer to overcome blocks in leukemic cell differentiation. Our results support the concept of low doses of 5-AZA-dC acting in combination with other agents to target epigenetic changes that drive malignant growth in leukemic cells.

Original languageEnglish (US)
Pages (from-to)55-64
Number of pages10
JournalCancer Research
Volume69
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

decitabine
Methyltransferases
Myeloid Cells
Acute Myeloid Leukemia
Tumor Necrosis Factor-alpha
DNA
Chromatin
Methylation
Cell Differentiation
Chromatin Immunoprecipitation
DNA Methylation
Growth
Epigenomics
Histones
Genes
Transcription Factors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Inhibition of DNA methyltransferase activates tumor necrosis factor α-induced monocytic differentiation in acute myeloid leukemia cells. / Laurenzana, Anna; Petruccelli, Luca A.; Pettersson, Filippa; Figueroa, Maria; Melnick, Ari; Baldwin, Albert S.; Paoletti, Francesco; Miller, Wilson H.

In: Cancer Research, Vol. 69, No. 1, 01.01.2009, p. 55-64.

Research output: Contribution to journalArticle

Laurenzana, Anna ; Petruccelli, Luca A. ; Pettersson, Filippa ; Figueroa, Maria ; Melnick, Ari ; Baldwin, Albert S. ; Paoletti, Francesco ; Miller, Wilson H. / Inhibition of DNA methyltransferase activates tumor necrosis factor α-induced monocytic differentiation in acute myeloid leukemia cells. In: Cancer Research. 2009 ; Vol. 69, No. 1. pp. 55-64.
@article{78c6d0cca3e543b08197a9ad61d7a941,
title = "Inhibition of DNA methyltransferase activates tumor necrosis factor α-induced monocytic differentiation in acute myeloid leukemia cells",
abstract = "Transcriptional silencing via promoter methylation of genes important for cell growth and differentiation plays a key role in myeloid leukemogenesis. We find that clinically achievable levels of 5-aza-2′-deoxycytidine (5-AZA-dC), a potent inhibitor of DNA methylation, can modify chromatin and restore the ability of tumor necrosis factor α (TNFα) to induce monocytic differentiation of the acute myeloid leukemia cells NB4 and U937. Although 5-AZA-dC cannot fully induce differentiation, we show that 5-AZA-dC acts directly on TNFα-responsive promoters to facilitate TNFα-induced transcriptional pathways leading to differentiation. 5-AZA-dC regulates the expression of Dif-2, a TNFα target gene, by deacetylating chromatin domains in a methylation-dependent manner. Chromatin immunoprecipitation analyses of the Dif-2 promoter show histone hyperacetylation and a recruitment of the nuclear factor-κB transcription factor in response to 5-AZA-dC. Furthermore, 5-AZA-dC plus TNFα enhances the level of phosphorylated RNAP ol II at the Dif-2 promoter via synergistic recruitment of TFIIH. We conclude that nonspecific changes in chromatin can allow a specific transcriptional inducer to overcome blocks in leukemic cell differentiation. Our results support the concept of low doses of 5-AZA-dC acting in combination with other agents to target epigenetic changes that drive malignant growth in leukemic cells.",
author = "Anna Laurenzana and Petruccelli, {Luca A.} and Filippa Pettersson and Maria Figueroa and Ari Melnick and Baldwin, {Albert S.} and Francesco Paoletti and Miller, {Wilson H.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-08-0245",
language = "English (US)",
volume = "69",
pages = "55--64",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Inhibition of DNA methyltransferase activates tumor necrosis factor α-induced monocytic differentiation in acute myeloid leukemia cells

AU - Laurenzana, Anna

AU - Petruccelli, Luca A.

AU - Pettersson, Filippa

AU - Figueroa, Maria

AU - Melnick, Ari

AU - Baldwin, Albert S.

AU - Paoletti, Francesco

AU - Miller, Wilson H.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Transcriptional silencing via promoter methylation of genes important for cell growth and differentiation plays a key role in myeloid leukemogenesis. We find that clinically achievable levels of 5-aza-2′-deoxycytidine (5-AZA-dC), a potent inhibitor of DNA methylation, can modify chromatin and restore the ability of tumor necrosis factor α (TNFα) to induce monocytic differentiation of the acute myeloid leukemia cells NB4 and U937. Although 5-AZA-dC cannot fully induce differentiation, we show that 5-AZA-dC acts directly on TNFα-responsive promoters to facilitate TNFα-induced transcriptional pathways leading to differentiation. 5-AZA-dC regulates the expression of Dif-2, a TNFα target gene, by deacetylating chromatin domains in a methylation-dependent manner. Chromatin immunoprecipitation analyses of the Dif-2 promoter show histone hyperacetylation and a recruitment of the nuclear factor-κB transcription factor in response to 5-AZA-dC. Furthermore, 5-AZA-dC plus TNFα enhances the level of phosphorylated RNAP ol II at the Dif-2 promoter via synergistic recruitment of TFIIH. We conclude that nonspecific changes in chromatin can allow a specific transcriptional inducer to overcome blocks in leukemic cell differentiation. Our results support the concept of low doses of 5-AZA-dC acting in combination with other agents to target epigenetic changes that drive malignant growth in leukemic cells.

AB - Transcriptional silencing via promoter methylation of genes important for cell growth and differentiation plays a key role in myeloid leukemogenesis. We find that clinically achievable levels of 5-aza-2′-deoxycytidine (5-AZA-dC), a potent inhibitor of DNA methylation, can modify chromatin and restore the ability of tumor necrosis factor α (TNFα) to induce monocytic differentiation of the acute myeloid leukemia cells NB4 and U937. Although 5-AZA-dC cannot fully induce differentiation, we show that 5-AZA-dC acts directly on TNFα-responsive promoters to facilitate TNFα-induced transcriptional pathways leading to differentiation. 5-AZA-dC regulates the expression of Dif-2, a TNFα target gene, by deacetylating chromatin domains in a methylation-dependent manner. Chromatin immunoprecipitation analyses of the Dif-2 promoter show histone hyperacetylation and a recruitment of the nuclear factor-κB transcription factor in response to 5-AZA-dC. Furthermore, 5-AZA-dC plus TNFα enhances the level of phosphorylated RNAP ol II at the Dif-2 promoter via synergistic recruitment of TFIIH. We conclude that nonspecific changes in chromatin can allow a specific transcriptional inducer to overcome blocks in leukemic cell differentiation. Our results support the concept of low doses of 5-AZA-dC acting in combination with other agents to target epigenetic changes that drive malignant growth in leukemic cells.

UR - http://www.scopus.com/inward/record.url?scp=58249110388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249110388&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-0245

DO - 10.1158/0008-5472.CAN-08-0245

M3 - Article

C2 - 19117987

AN - SCOPUS:58249110388

VL - 69

SP - 55

EP - 64

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 1

ER -